Literature DB >> 28540339

Leukocyte Telomere Length and Serum Levels of High-Molecular-Weight Adiponectin and Dehydroepiandrosterone-Sulfate Could Reflect Distinct Aspects of Longevity in Japanese Centenarians.

Yuji Aoki1, Masato Aoki2, Kazuya Yamada2.   

Abstract

Leukocyte telomere length and serum levels of high-molecular-weight adiponectin and dehydroepiandrosterone-sulfate (DHEA-S) were assessed in association with nutrition and performance status (PS) in Japanese centenarians. Twenty-three centenarians (five men, 18 women) were classified according to their PS 1 (nearly fully ambulatory, n = 2), 2 (in bed less than 50% of daytime, n = 10), 3 (in bed greater than 50%, n = 6), and 4 (completely bedridden, n = 5). Leukocyte telomere length was determined by the hybridization protection assay, and the adiponectin and DHEA-S levels were measured by chemiluminescent enzyme immunoassay. Among variables of PS, body mass index (BMI), albumin, adiponectin, DHEA-S, and telomere length, there were significant correlations between PS and albumin (r = -.694, p < .01), between telomere length and BMI (r = .522, p < .05), between adiponectin and BMI (r = -.574, p < .01), and between DHEA-S and albumin (r = .530, p < .01). When excluding two cancer-bearing centenarians with short telomere, telomere length significantly correlated with PS (r = -.632, p < .01). It was indicated that the short leukocyte telomere was associated with poor PS and cancer development and that the adiponectin or DHEA-S was associated with adiposity or nutritional status. Despite a small number of subjects, these biomarkers seemed to reflect distinct aspects of longevity in Japanese centenarians.

Entities:  

Keywords:  centenarians; dehydroepiandrosterone-sulfate; high-molecular-weight adiponectin; leukocyte telomere length; longevity

Year:  2017        PMID: 28540339      PMCID: PMC5433671          DOI: 10.1177/2333721417696672

Source DB:  PubMed          Journal:  Gerontol Geriatr Med        ISSN: 2333-7214


Introduction

Telomeres consist of 500 to 2,000 tandem repeats of a hexanucleotide (TTAGGG) in the 5′-strand of DNA at the ends of linear chromosomes in human cells. The associated proteins coating the telomeric DNA sequence prevent the cellular DNA repair machinery from mistaking telomeres for double-stranded DNA breaks, potentially leading to chromosomal deletions, inversions, and translocations (de Lange, 2005; Young, 2010). Telomeres progressively shorten with each cell division in cultured somatic cells, reaching to a critically shortened length with replicative senescence. Telomere shortening is considered a biomarker of cellular aging, and telomere length in leukocytes is usually measured to assess its inverse association with age-related morbidity and mortality (Brouilette, Singh, Thompson, Goodall, & Samani, 2003; Cawthon, Smith, O’Brien, Sivatchenko, & Kerber, 2003; Demissie et al., 2006; Honig, Schupf, Lee, Tang, & Mayeux, 2006). However, such associations have not clearly been demonstrated in centenarians or the oldest old (Bischoff et al., 2006; Martin-Ruiz, Gussekloo, van Heemst, von Zglinicki, & Westendorp, 2005). While centenarians who have generally been spared major age-related diseases had better maintenance of telomere length (Arai et al., 2015; Terry, Nolan, Andersen, Perls, & Cawthon, 2008), healthy centenarians had longer telomeres (Atzmon et al., 2010). Studies on telomere length in centenarians are still scarce. We made a field survey on health status of Japanese centenarians and reported on breath hydrogen gas in the previous study (Aoki, 2013). In the present study, leukocyte telomere length was assessed in association with nutrition and performance status (PS) of the centenarians whose telomere length could be determined in the stored DNA samples extracted from the peripheral blood. Serum levels of high-molecular-weight adiponectin and dehydroepiandrosterone-sulfate (DHEA-S), which are also known to be associated with aging or longevity (Arai & Hirose, 2012; Gulcelik, Halil, Ariogul, & Usman, 2013; Nair et al., 2006; Sanders et al., 2010; Yen, 2001), were simultaneously assessed in the Japanese centenarians.

Method

Subjects

As described in the previous report (Aoki, 2013), people aged 100 years and above (centenarians) during the fiscal year 2010 in Matsumoto city (135 people out of 242,000 citizens) and Shiojiri city (35 people out of 68,000 citizens) were asked by post whether they would agree to participate in the study, which was approved by the Ethical Review Board of National Hospital Organization Matsumoto Medical Center. The written consent was obtained from 39 centenarians by return of post, but we were able to visit only 28 centenarians in their own homes or nursing homes due to their inconvenience to our schedule. Because the amount of DNA stored was not enough for the assay used in this study, telomere length could not be determined in five out of 28 DNA samples. And then, 23 centenarians were studied in this report. In Table 1, clinical characteristics and laboratory data of 23 centenarians, who were all nonsmokers (including three ex-smokers) and nondrinkers (including five occasional drinkers), were shown when classified according to the Eastern Cooperative Oncology Group scale of PS (Sorensen, Klee, Palshof, & Hansen, 1993): PS 0 means normal activity (n = 0); PS 1 means some symptoms, but still nearly fully ambulatory (n = 2); PS 2 means less than 50% of daytime in bed (n = 10); PS 3 means greater than 50% of daytime in bed (n = 6); and PS 4 means completely bedridden (n = 5). Two centenarians who bore prostatic cancer (hormone therapy) and skin cancer (liquid nitrogen therapy) belonged to PS 1 and 2, respectively. Three centenarians survived cancers in the past: gastric cancer in PS 2, tongue cancer in PS 3, and breast cancer in PS 4 (not shown).
Table 1.

Clinical Characteristics and Laboratory Data of Centenarians Classified by PS (PS 1-4).

PS
PS 1PS 2PS 3PS 4
n 21065
Male/female1/11/92/41/4
Age (years)101 (1)101 (2)101 (1)103 (3)
Height (cm)143 (11)143 (9)142 (8)142 (8)
Weight (kg)41 (2)41 (8)39 (8)36 (5)
Body mass index20.2 (4.0)19.7 (1.7)19.2 (2.8)17.5 (1.6)
Comorbidities
 Hypertension (n)1841
 Diabetes mellitus (n)0100
 Hypercholesterolemia (n)0100
 Heart failure (n)0320
 Cerebral infarction (n)0203
 Dementia (n)0222
 Cancer (n)1100
Laboratory data
 Total protein (g/dl)7.2 (0.4)6.9 (0.7)6.2 (1.0)6.0 (0.4)
 Albumin (g/dl)4.4 (0.1)3.8 (0.5)3.0 (0.6)3.0 (0.6)
 LDL-chol (mg/dl)123 (47)109 (28)73 (24)88 (21)
 HDL-chol (mg/dl)45 (23)48 (17)41 (8)45 (17)
 Triglyceride (mg/dl)165 (129)127 (59)79 (41)91 (18)
 Glucose (mg/dl)94 (34)83 (20)90 (22)86 (32)
 Creatinine (mg/dl)0.9 (0.2)0.9 (0.3)0.7 (0.2)0.5 (0.2)

Note. The values represent M (SD); heart failure, excluding NYHA Class I; cerebral infarction, excluding silent lacunar infarction. PS = performance status; LDL-chol = low-density lipoprotein cholesterol; HDL-chol = high-density lipoprotein cholesterol; NYHA = New York Heart Association.

Clinical Characteristics and Laboratory Data of Centenarians Classified by PS (PS 1-4). Note. The values represent M (SD); heart failure, excluding NYHA Class I; cerebral infarction, excluding silent lacunar infarction. PS = performance status; LDL-chol = low-density lipoprotein cholesterol; HDL-chol = high-density lipoprotein cholesterol; NYHA = New York Heart Association.

Telomere Measurement

From the whole blood samples, DNA was extracted by using a AxyPrep Whole Blood Genomic DNA Miniprep kit (Axygen, CA, USA) according to its instruction, and stored at −20°C until used. Total telomeres were measured by MiRTeL Co. Ltd. (Hiroshima, Japan) using the hybridization protection assay (HPA; Hirashio et al., 2014; Nakamura et al., 1999). Briefly, the extracted DNA was adjusted to 40 ng/µl, and after the DNA solution was heat denatured for 5 min at 95°C, a telomere HPA probe labeled with acridinium ester (AE; 5′-CCC TAA CCC TAA CC*C TAA CTC TGC TCG AC-3′, where * indicates the AE position) was added and incubated at 60°C for 20 min. After hydrolyzation of unhybridized probe, chemiluminescence of AE was measured by a luminometer. Total telomeres are represented as luminescence signals in relative light units (rlu) per 400 ng genomic DNA.

Other Measurements

Blood samples were taken between 11:00 and 18:00 after meals, and stored in serum at −20°C until used. Serum high-molecular-weight adiponectin and DHEA-S levels were measured with chemiluminescent enzyme immunoassay. Serum levels of total protein, albumin, low-density lipoprotein (LDL) cholesterol, high-density lipoprotein (HDL) cholesterol, triglyceride, glucose, and creatinine were measured by an automated analyzer. All these measurements were performed by a referee laboratory (SRL Inc., Tokyo, Japan).

Statistical Analysis

Data are expressed as the mean (SD). Linear associations among continuous variables were assessed by Pearson’s correlation coefficient, and those between PS (categorical variable) and other variables were assessed by Spearman’s rank correlation coefficient, with a significance level at p < .05.

Results

In Association With PS

As shown in Table 1, centenarians with better PS had higher mean levels of body mass index (BMI), serum total protein, albumin, LDL cholesterol, triglyceride, and creatinine. Figure 1 shows leukocyte telomere length, serum albumin, adiponectin, and DHEA-S in PS 1 to 4, respectively. The telomere length was 18,948 (14,047) rlu in PS 1, 47,217 (20,041) rlu in PS 2, 41,051 (18,893) rlu in PS 3, and 14,540 (6,127) rlu in PS 4 (Figure 1A). The levels of albumin, adiponectin, and DHEA-S (Figure 1B-1D) were 4.4 (0.1) g/dl, 6.7 (6.8) µg/ml, and 50.5 (13.4) µmol/L in PS 1; 3.8 (0.5) g/dl, 10.7 (5.3) µg/ml, and 38.4 (19.2) µmol/L in PS 2; 3.0 (0.6) g/dl, 10.6 (3.2) µg/ml, and 21.0 (14.8) µmol/L in PS 3; and 3.0 (0.6) g/dl, 10.6 (4.4) µg/ml, and 29.8 (12.3) µmol/L in PS 4. The albumin and DHEA-S levels appear to decrease with PS worsening. A symbol ‘†’ denotes a cancer-bearing centenarian whose leukocyte telomere length was apparently short (9,015 and 6,478 rlu). The measurements of telomere length in leukocytes from three centenarians who survived cancer in the past were 38,333, 36,978, and 22,920 rlu (not specified in Figure 1).
Figure 1.

Associations of (A) leukocyte telomere length, (B) serum albumin, (C) serum high-molecular-weight adiponectin, and (D) serum dehydroepiandrosterone-sulfate with performance status (PS 1-4) in 23 centenarians as shown in Table 1.

Note. PS = performance status.

†Centenarian bearing cancer.

Associations of (A) leukocyte telomere length, (B) serum albumin, (C) serum high-molecular-weight adiponectin, and (D) serum dehydroepiandrosterone-sulfate with performance status (PS 1-4) in 23 centenarians as shown in Table 1. Note. PS = performance status. †Centenarian bearing cancer.

Correlation Matrix Among Aging-Related Variables

Table 2 shows correlation coefficients among variables of PS 1 to 4, BMI, albumin, adiponectin, DHEA-S, and telomere length in 23 centenarians. PS (PS 1-4) significantly (p < .01) correlated with serum albumin level (r = −.694). There were significant correlations between telomere length and BMI (r = .522, p < .05), between adiponectin and BMI (r = −.574, p < .01), and between DHEA-S and albumin (r = .530, p < .01). When excluding two cancer-bearing centenarians, telomere length significantly correlated with PS (r = −.632, p < .01).
Table 2.

Correlation Matrix Among Aging-Related Variables.

PSBMIAlbuminAdiponectinDHEA-STelomere
PS scale1.000−.365−.694**.137−.329−.391
BMI1.000.270−.574**−.020.522*
Albumin1.000−.260.530**.270
Adiponectin1.000.070−.208
DHEA-S1.000−.179
Telomere1.000

Note. Calculated using BMI and data in Figure 1. PS = performance status; BMI = body mass index; DHEA-S = dehydroepiandrosterone-sulfate.

p < .05. **p < .01.

Correlation Matrix Among Aging-Related Variables. Note. Calculated using BMI and data in Figure 1. PS = performance status; BMI = body mass index; DHEA-S = dehydroepiandrosterone-sulfate. p < .05. **p < .01.

Discussion

It has been demonstrated that serum albumin levels affected by nutritional and inflammatory status were correlated with PS (Han, Huang, Li, Hou, & Wu, 2015). The present study on centenarians also showed a significant correlation between serum albumin and PS. Unexpectedly, the leukocyte telomere length was not found to be significantly correlated with PS, although healthier centenarians have been demonstrated to have longer telomeres (Atzmon et al., 2010). Interestingly, however, the correlation between telomere length and PS became significant when two cancer-bearing centenarians were excluded. Most observational studies have demonstrated that people with inactive and unhealthy lifestyles had shorter telomeres potentially related to stress hormones, inflammation, and oxidative stress (Cherkas et al., 2008; Crous-Bou et al., 2014; Lin, Epel, & Blackburn, 2012; Sen et al., 2014; Starkweather et al., 2014). Telomere shortening seems to reflect age-related oxidative stress rather than mitotic clock, as discussed by Koliada, Krasnenkov, and Vaiserman (2015). With regard to telomere attrition and cancer, Calado and Young (2009) describe that telomere shortening can modestly contribute to oncogenesis in general and may be the critical factor in promoting the development of cancer in some specific inflammation and immune diseases. Although telomere length is commonly measured only in circulating blood leukocytes, the telomere length has been documented to be inversely correlated with cancer incidence and mortality (Willeit, Willeit, Kloss-Brandstaetter, Kronenberg, & Kiechl, 2011; Willeit et al., 2010). The authors speculate that aging of leukocytes reflected by short telomere length may impair immune surveillance and reduce the clearance of tumor cells (Willeit et al., 2010). In our study, two cancer-bearing centenarians had short leukocyte telomeres in spite of better PS. Three other centenarians who had survived cancers did not have short leukocyte telomeres, but their leukocyte telomeres might have been lengthened due to telomere dynamics in leukocytes (Broccoli, Young, & de Lange, 1995; Epel, 2012; Ornish et al., 2013; Willeit et al., 2010). In the present study, no significant correlation was found between leukocyte telomere length and serum high-molecular-weight adiponectin or DHEA-S level. Large-scale studies (Broer et al., 2014; Diaz, Mainous, Player, & Everett, 2010) showed no significant correlation between telomere length and adiponectin, but one study (Al-Attas et al., 2010) demonstrated its positive association with adiponectin as well as negative association with BMI (27.1 [4.9] in males, 29.6 [6.2] in females) in middle-aged obese Arabs. In our study, a positive association was found between telomere length and BMI (19.1 [2.2] in total) in lean Japanese centenarians, suggesting a potential role of nutritional status rather than adiposity on telomere length. Still, serum adiponectin level was found to be inversely correlated with BMI, as is commonly shown (Guenther et al., 2014; Lara-Castro, Luo, Wallace, Klein, & Garvey, 2006). Although age-related decline in serum DHEA-S (Nair et al., 2006) and age-related telomere attrition (Young, 2010) are noted, no association between them has been demonstrated (Li et al., 2014; Vasunilashorn & Cohen, 2014). In our study on centenarians, serum DHEA-S level was not correlated with leukocyte telomere length but was positively correlated with serum albumin level. Because DHEA-S is bound to serum albumin, serum DHEA-S level is affected by serum albumin level (Carlstroem, Karlsson, & Von Schoultz, 2002). Both the serum DHEA-S and albumin levels were presumed to reflect nutritional status in the centenarians studied. The present study showed that short leukocyte telomere length was associated with poor PS and cancer development, as is regarded in general. Serum levels of adiponectin and DHEA-S were indicated to reflect adiposity and nutritional status, respectively. Despite a small number of subjects, these biomarkers, leukocyte telomere length and serum levels of high-molecular-weight adiponectin and DHEA-S, seemed to reflect distinct aspects of longevity in Japanese centenarians. As leukocyte telomere may be lengthened by nutrition and lifestyle interventions (Boccardi, Paolisso, & Mecocci, 2016) or some small molecules (Townsley et al., 2016), leukocyte telomere length could be a feasible and encouraging biomarker for aged people who wish to be healthier centenarians.
  41 in total

1.  Shorter telomeres are associated with mortality in those with APOE epsilon4 and dementia.

Authors:  Lawrence S Honig; Nicole Schupf; Joseph H Lee; Ming X Tang; Richard Mayeux
Journal:  Ann Neurol       Date:  2006-08       Impact factor: 10.422

2.  Effect of comprehensive lifestyle changes on telomerase activity and telomere length in men with biopsy-proven low-risk prostate cancer: 5-year follow-up of a descriptive pilot study.

Authors:  Dean Ornish; Jue Lin; June M Chan; Elissa Epel; Colleen Kemp; Gerdi Weidner; Ruth Marlin; Steven J Frenda; Mark Jesus M Magbanua; Jennifer Daubenmier; Ivette Estay; Nancy K Hills; Nita Chainani-Wu; Peter R Carroll; Elizabeth H Blackburn
Journal:  Lancet Oncol       Date:  2013-09-17       Impact factor: 41.316

3.  DHEA in elderly women and DHEA or testosterone in elderly men.

Authors:  K Sreekumaran Nair; Robert A Rizza; Peter O'Brien; Ketan Dhatariya; Kevin R Short; Ajay Nehra; Janet L Vittone; George G Klee; Ananda Basu; Rita Basu; Claudio Cobelli; Gianna Toffolo; Chiara Dalla Man; Donald J Tindall; L Joseph Melton; Glenn E Smith; Sundeep Khosla; Michael D Jensen
Journal:  N Engl J Med       Date:  2006-10-19       Impact factor: 91.245

4.  Cardiovascular disease is associated with greater incident dehydroepiandrosterone sulfate decline in the oldest old: the cardiovascular health study all stars study.

Authors:  Jason L Sanders; Robert M Boudreau; Anne R Cappola; Alice M Arnold; John Robbins; Mary Cushman; Anne B Newman
Journal:  J Am Geriatr Soc       Date:  2010-02-16       Impact factor: 5.562

5.  Telomere length and adiposity in a racially diverse sample.

Authors:  V A Diaz; A G Mainous; M S Player; C J Everett
Journal:  Int J Obes (Lond)       Date:  2009-09-22       Impact factor: 5.095

6.  Association between telomere length in blood and mortality in people aged 60 years or older.

Authors:  Richard M Cawthon; Ken R Smith; Elizabeth O'Brien; Anna Sivatchenko; Richard A Kerber
Journal:  Lancet       Date:  2003-02-01       Impact factor: 79.321

Review 7.  How "reversible" is telomeric aging?

Authors:  Elissa Epel
Journal:  Cancer Prev Res (Phila)       Date:  2012-10

8.  No association between telomere length and survival among the elderly and oldest old.

Authors:  Claus Bischoff; Hans Christian Petersen; Jesper Graakjaer; Karen Andersen-Ranberg; James W Vaupel; Vilhelm A Bohr; Steen Kølvraa; Kaare Christensen
Journal:  Epidemiology       Date:  2006-03       Impact factor: 4.822

9.  The prognostic role of preoperative serum albumin levels in glioblastoma patients.

Authors:  Sheng Han; Yanming Huang; Zhonghua Li; Haipei Hou; Anhua Wu
Journal:  BMC Cancer       Date:  2015-03-08       Impact factor: 4.430

10.  Inflammation, But Not Telomere Length, Predicts Successful Ageing at Extreme Old Age: A Longitudinal Study of Semi-supercentenarians.

Authors:  Yasumichi Arai; Carmen M Martin-Ruiz; Michiyo Takayama; Yukiko Abe; Toru Takebayashi; Shigeo Koyasu; Makoto Suematsu; Nobuyoshi Hirose; Thomas von Zglinicki
Journal:  EBioMedicine       Date:  2015-07-29       Impact factor: 8.143

View more
  1 in total

1.  Gut-Derived Endotoxin and Telomere Length Attrition in Adults with and without Type 2 Diabetes.

Authors:  Nasser M Al-Daghri; Saba Abdi; Shaun Sabico; Abdullah M Alnaami; Kaiser A Wani; Mohammed G A Ansari; Malak Nawaz Khan Khattak; Nasiruddin Khan; Gyanendra Tripathi; George P Chrousos; Philip G McTernan
Journal:  Biomolecules       Date:  2021-11-14
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.